Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(3 sites)
United States
Orlando Clinical Research Center, Orlando, Florida American Research Corporation, San Antonio, Texas Hungary
CRU Early Phase Unit, Kistarcsa